Table 2.
Demographics and influenza vaccination of subjects in this study
| Season 1 (2015)a | Season 2 (2016)a | Totala | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Male | Prior | Female | Prior | Male | Prior | Female | Prior | ||
| FluBlok | 4 (1) | 1 | 6 (2) | 0 | 5 (1) | 4 | 17 (2) | 9 | 32 (3) |
| FluCelvax | 6 (4) | 1 | 6 (4) | 0 | 9 (4) | 3 | 17 (4) | 6 | 38 (8) |
| Fluzone | 5 (2) | 1 | 4 (3) | 0 | 11 (2) | 8 | 11 (3) | 5 | 31 (5) |
| Total | 15 (7) | 3 | 16 (9) | 0 | 25 (7) | 15 | 45 (9) | 20 | 101 (16) |
aNumbers in parenthesis indicate individuals who are repeatedly vaccinated with same vaccine in both years. Prior are those subjects who received inactivated seasonal influenza vaccine in the previous year of this study